Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 7
2004 3
2005 7
2006 3
2007 1
2008 5
2009 8
2010 6
2011 16
2012 17
2013 17
2014 18
2015 17
2016 23
2017 30
2018 40
2019 55
2020 73
2021 73
Text availability
Article attribute
Article type
Publication date

Search Results

388 results
Results by year
Filters applied: . Clear all
Page 1
An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness.
Quan MY, Guo Q, Liu J, Yang R, Bai J, Wang W, Cai Y, Han R, Lv YQ, Ding L, Billadeau DD, Lou Z, Bellusci S, Li X, Zhang JS. Quan MY, et al. Among authors: han r. Front Cell Dev Biol. 2020 May 7;8:287. doi: 10.3389/fcell.2020.00287. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32457900 Free PMC article.
Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial.
Li L, Jiang L, Wang Y, Zhao Y, Zhang XJ, Wu G, Zhou X, Sun J, Bai J, Ren B, Tian K, Xu Z, Xiao HL, Zhou Q, Han R, Chen H, Wang H, Yang Z, Gao C, Cai S, He Y. Li L, et al. Among authors: han r. Clin Cancer Res. 2019 Dec 1;25(23):6967-6975. doi: 10.1158/1078-0432.CCR-19-0437. Epub 2019 Aug 14. Clin Cancer Res. 2019. PMID: 31413010 Free article. Clinical Trial.
388 results